Sensorion Seeks Partner For Inner Ear Disorder Drug
Executive Summary
Sensorion CEO Nawal Ouzren speaks to Scrip's Lucie Ellis on the sidelines of the recent BIO-Europe partnering meeting about the company's two clinical-stage programs that are targeting inner ear conditions.